Full-Time

Inventory Specialist

Posted on 9/23/2024

Umoja Biopharma

Umoja Biopharma

51-200 employees

Develops in vivo CAR T-cell therapies

Biotechnology
Healthcare

Compensation Overview

$23 - $27.9Hourly

Mid

Lafayette, CO, USA

Required to be onsite 5 days a week.

Category
Administrative & Executive Assistance
Specialized Administrative Roles
Required Skills
Communications
Management
Data Analysis
Excel/Numbers/Sheets
Requirements
  • A GED or equivalent degree with 3 years of experience in inventory management, preferably in a GMP-regulated environment.
  • Advanced proficiency in Microsoft Excel, including expertise in pivot tables, VLOOKUP, and other data management functions.
  • Strong analytical skills and attention to detail.
  • Excellent organizational and problem-solving skills.
  • Ability to work independently and as part of a team.
  • Strong communication skills, both written and verbal.
  • Knowledge of GMP guidelines and their application in inventory management.
Responsibilities
  • Monitor and maintain stock levels through regular physical and system checks, ensuring accuracy and efficiency in inventory counts.
  • Utilize advanced Excel functions to create and manage detailed spreadsheets; experience with pivot tables and data analysis is crucial.
  • Implement and maintain inventory management systems to accurately track, record, and report inventory status.
  • Coordinate with procurement and warehouse departments to optimize inventory levels and replenish stock as needed.
  • Conduct regular audits to ensure compliance with GMP standards and internal policies.
  • Resolve discrepancies between inventory records and physical stock quickly and accurately.
  • Prepare detailed reports and forecasts related to inventory for upper management, highlighting potential issues and improvements.
  • Assist in developing and implementing improvements to existing inventory management procedures to increase efficiency and accuracy.
  • Operating the warehouse according to Umoja SOPs and Quality Systems.

Umoja Biopharma focuses on immunotherapy by reprogramming T cells in the body to target and destroy cancer cells. Unlike traditional methods that modify cells outside the body, Umoja's approach modifies the immune system in vivo, aiming for long-lasting remissions. The company primarily targets patients with solid tumors and hematological cancers that have not responded to other treatments. Its business model is based on developing and commercializing a proprietary CAR T-cell gene therapy platform that is scalable and can treat cancers at various stages. By producing off-the-shelf therapies in-house, Umoja can distribute its treatments more efficiently than those requiring individual customization. The goal is to enhance cancer treatment through effective use of the immune system.

Company Stage

Series B

Total Funding

$255.8M

Headquarters

Seattle, Washington

Founded

2019

Growth & Insights
Headcount

6 month growth

-4%

1 year growth

3%

2 year growth

37%
Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic collaboration with AbbVie provides $1.44 billion support for CAR-T development.
  • Seattle's biotech growth offers a robust ecosystem for talent and resources.
  • Experienced leaders like Scott Myers enhance strategic growth and financial management.

What critics are saying

  • Dependency on AbbVie may influence Umoja's CAR-T therapy development.
  • Seattle's biotech growth may intensify competition for skilled professionals.
  • In vivo CAR-T therapies may face regulatory hurdles and longer approval timelines.

What makes Umoja Biopharma unique

  • Umoja Biopharma reprograms T cells in vivo, unlike traditional ex vivo methods.
  • Their CAR T-cell platform is scalable, treating cancers at every stage.
  • Off-the-shelf therapies allow efficient production and distribution, reducing customization needs.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE